The PPOL lab network
The PPOL lab is connected to a broad (inter)national network of labs and research communities worldwide, sharing knowledge and working on joint solutions for (childhood) cancer.
PPOL is a member of the CRIG network in Ghent
Cancer remains a major public health concern, with one in three men and one in four women in Belgium diagnosed before the age of 75. Despite significant progress in recent decades, the biological mechanisms that drive cancer development and progression are still not fully understood, posing ongoing challenges for researchers striving to develop more effective, targeted therapies. Ghent University (UGent), Ghent University Hospital (UZ Gent), and VIB-UGent (a leading life sciences research institute in Flanders) have built a strong and internationally recognized track record in cancer research. Across these institutions, research teams have developed strong expertise in diverse areas, contributing to important advances in cancer biology, diagnostics, and treatment. These efforts have also led to the clinical implementation of novel therapies and diagnostic tools.
However, much of this expertise remains dispersed across various campuses and departments. The Cancer Research Institute Ghent (CRIG) was established to address this fragmentation. CRIG’s mission is to unify and support cancer research efforts at UGent, UZ Gent, and VIB-UGent, fostering collaboration, stimulating innovation, and maximizing the societal and clinical impact of cancer research in the region.
Learn more about CRIG by visiting their website HERE.
However, much of this expertise remains dispersed across various campuses and departments. The Cancer Research Institute Ghent (CRIG) was established to address this fragmentation. CRIG’s mission is to unify and support cancer research efforts at UGent, UZ Gent, and VIB-UGent, fostering collaboration, stimulating innovation, and maximizing the societal and clinical impact of cancer research in the region.
Learn more about CRIG by visiting their website HERE.
PPOL closely connects to the clinic and diagnostic department of the University Hospital Campus in Ghent
The PPOL lab also maintains close connections to the pediatric hemato-oncology department of the UZ Ghent (prof. Tim Lammens, prof. dr. Bram De Wilde,...) as well as with the molecular diagnostics department (prof. dr. Nadine Van Roy, dr. Joni Van Der Meulen, dr. Siebe Loontiens,...). This enables us to stay closely connected to both the clinical and diagnostic aspects of research.
POLL members actively participate in BSPHO task forces
|
The Belgian Society of Paediatric Haematology and Oncology (BSPHO) is a collaboration between professionals of the recognized Belgian centres in paediatric haemato-oncology to share expertise and knowledge to improve treatment of childhood cancer and patient care.
Different members of the PPOL team also actively participate in different BSPHO task forces. Learn more about the BSPHO HERE. |
PPOL is part of the consortium for sarcoma research Ghent (ConSaRGhent)
At Ghent University and Ghent University Hospital, several researchers are joining forces to optimize sarcoma research. Together with other research groups, we are creating the opportunity to investigate and compare several in-vitro and in-vivo/ex-vivo sarcoma models.
As partner of ConSaRGhent, we aim to improve multidisciplinary research on sarcoma. A variety of both clinical and translational researchers that are specialized in different fields are part of the team. This collaboration will elevate our research with as most important aim to improve our understanding of sarcoma biology and outcomes in both human and veterinary patients.
Learn more about the ConSaRGHent HERE.
As partner of ConSaRGhent, we aim to improve multidisciplinary research on sarcoma. A variety of both clinical and translational researchers that are specialized in different fields are part of the team. This collaboration will elevate our research with as most important aim to improve our understanding of sarcoma biology and outcomes in both human and veterinary patients.
Learn more about the ConSaRGHent HERE.
PPOL is involved in different European networks
The ITCC network
The Innovative Therapies for Children and adolescents with Cancer (ITCC) consortium is a clinical trials network focused on delivering new treatments for children and adolescents with cancer through collaborative research and clinical trials. The ITCC consortium stands as one of the largest collaborative groups in the field of paediatric oncology, uniting leading paediatric oncology centres, researchers, and industry partners across Europe and beyond. With 62 sites across 17 countries, they have investigated 75 therapies, completed 55 studies and recruited 3387 patients. Since we are part of this network, the ITCC can further support us to bring our interesting findings from the lab into the clinic.
Learn more about the ITCC network HERE.
SIOPEN
The SIOPEN - The Neuroblastoma Research Network is an association that aims to perform and facilitate clinical, translational and basic research for children and adolescents with neuroblastoma in European countries as well as worldwide in order to improve the outcome of these patients.
Learn more about the SIOPEN HERE.
EpSSG
The European Paediatric Soft tissue Sarcoma study Group (EpSSG) Association exists to promote and manage clinical trials, encourage and facilitate clinical and basic science research, foster optimal standards of care, organise educational meetings for its members and other professionals, and advocate for patients with soft tissue sarcomas.
Learn more about the SIOPEN HERE.
The Innovative Therapies for Children and adolescents with Cancer (ITCC) consortium is a clinical trials network focused on delivering new treatments for children and adolescents with cancer through collaborative research and clinical trials. The ITCC consortium stands as one of the largest collaborative groups in the field of paediatric oncology, uniting leading paediatric oncology centres, researchers, and industry partners across Europe and beyond. With 62 sites across 17 countries, they have investigated 75 therapies, completed 55 studies and recruited 3387 patients. Since we are part of this network, the ITCC can further support us to bring our interesting findings from the lab into the clinic.
Learn more about the ITCC network HERE.
SIOPEN
The SIOPEN - The Neuroblastoma Research Network is an association that aims to perform and facilitate clinical, translational and basic research for children and adolescents with neuroblastoma in European countries as well as worldwide in order to improve the outcome of these patients.
Learn more about the SIOPEN HERE.
EpSSG
The European Paediatric Soft tissue Sarcoma study Group (EpSSG) Association exists to promote and manage clinical trials, encourage and facilitate clinical and basic science research, foster optimal standards of care, organise educational meetings for its members and other professionals, and advocate for patients with soft tissue sarcomas.
Learn more about the SIOPEN HERE.
PPOL closely collaborates with multiple (inter)national research groups
|
|
